Abstract
Anxiety Disorders often show a chronic course, even when treated with one of the various effective treatments available. Lack of treatment effect could be due to Treatment Resistance (TR). Consensus on a definition for TR Anxiety Disorders (TR‐AD) is highly needed as currently many different operationalizations are in use. Therefore, generalizability in current TR‐AD research is suboptimal, hampering improvement of clinical care. The objective of this review is to evaluate the currently used definitions of TR‐AD by performing a systematic review of available literature. Out of a total of n = 13 042, 62 studies that operationalized TR‐AD were included. The current review confirms a lack of consensus on TR‐AD criteria. In 62.9% of the definitions, TR was deemed present after the first treatment failure. Most studies (93.0%) required pharmacological treatment failures, whereas few (29.0%) required psychological treatment failures. However, criteria for what constitutes “treatment failure” were not provided in the majority of studies (58.1%). Definitions for minimal treatment duration ranged from at least 4 weeks to at least 6 months. Almost half of the TR‐AD definitions (46.8%) required elevated anxiety severity levels in TR‐AD. After synthesis of the results, the consensus definition considers TR‐AD present after both at least one first‐line pharmacological and one psychological treatment failure, provided for an adequate duration (at least 8 weeks) with anxiety severity remaining above a specified threshold. This definition could contribute to improving course prediction and identifying more targeted treatment options for the highly burdened subgroup of TR‐AD patients.
Highlights
Up till a widely used definition for treatment resistance in anxiety disorders does not exist (Barton, Karner, Salih, Baldwin, & Edwards, 2014; Chen & Tsai, 2016; Roy‐Byrne, 2015; Starcevic, 2008; Stein, 2004)
The aim of this study is to summarize and discuss the different criteria used for Treatment Resistance (TR)‐AD
Out of ten putative criteria, we identified six criteria that are regularly integrated into the various different definitions for Treatment Resistant Anxiety Disorders (TR‐AD): minimal number of treatment failures, presence of psychological treatment failure, presence of pharmacological treatment failure, minimal treatment duration (>8 weeks), specification of a response criterion, and minimal symptom severity
Summary
A widely used definition for treatment resistance in anxiety disorders does not exist (Barton, Karner, Salih, Baldwin, & Edwards, 2014; Chen & Tsai, 2016; Roy‐Byrne, 2015; Starcevic, 2008; Stein, 2004). This is surprising because it is well known that a substantial proportion of adults with Anxiety Disorders experience suboptimal treatment results after evidence‐based treatments (Bruce et al, 2005; Huh, Goebert, Takeshita, Lu, & Kang, 2011; Ramsawh, Raffa, Edelen, Rende, & Keller, 2009). After first‐ line treatment up till 30–60% of patients have substantial and impairing remaining symptoms (Bandelow et al, 2008; Bruce et al, 2005; Tyrer, Seivewright, & Johnson, 2004)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
